Friday, February 24, 2017 8:59:27 AM
It does appear there is a large number of companies competing in this generic. I wonder if they will manufacture the drug themselves and keep a bigger piece of the pie?
it appears we have 20-40 competitors? FDA orange book has 80 entries divide by two you get 40. There could be some duplicates I haven't gone through the listings that don't list the specific manufacturer in the summary page.
Another Drug manufacturer web site has the following list so our partner is a company not on the list...orange book has a more comprehensive listing...teva is amongst the list...I wonder if Endo/Par has a product in the works?
Manufacturer: ACTAVIS LABS FL INC
Approval date: June 16, 2004
Strength(s): 500MG [AB1]
Manufacturer: ACTAVIS LABS FL INC
Approval date: April 12, 2005
Strength(s): 750MG [AB]
Manufacturer: AMNEAL PHARMS NY
Approval date: January 3, 2008
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: APOTEX
Approval date: December 14, 2004
Strength(s): 500MG [AB1]
Manufacturer: APOTEX
Approval date: December 29, 2005
Strength(s): 750MG [AB]
Manufacturer: AUROBINDO PHARMA LTD
Approval date: July 20, 2012
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: BARR
Approval date: October 14, 2004
Strength(s): 750MG [AB]
Manufacturer: BEXIMCO PHARMS USA
Approval date: December 13, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: CSPC OUYI PHARM CO
Approval date: April 17, 2008
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: INVENTIA HLTHCARE
Approval date: January 18, 2012
Strength(s): 500MG [AB1]
Manufacturer: MACLEODS PHARMS LTD
Approval date: December 7, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: MARKSANS PHARMA
Approval date: April 29, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: MYLAN
Approval date: September 8, 2005
Strength(s): 750MG [AB]
Manufacturer: MYLAN
Approval date: September 13, 2005
Strength(s): 500MG [AB1]
Manufacturer: NOSTRUM PHARMS LLC
Approval date: July 26, 2006
Strength(s): 500MG [AB1]
Manufacturer: NOSTRUM PHARMS LLC
Approval date: December 12, 2011
Strength(s): 750MG [AB]
Manufacturer: SANDOZ
Approval date: December 14, 2004
Strength(s): 500MG [AB1]
Manufacturer: SUN PHARM INDS (IN)
Approval date: February 9, 2006
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: TEVA
Approval date: June 18, 2004
Strength(s): 500MG [AB1]
Manufacturer: TEVA
Approval date: April 12, 2005
Strength(s): 750MG [AB]
Manufacturer: TORRENT PHARM
Approval date: December 30, 2009
Strength(s): 500MG [AB1]
Manufacturer: ZYDUS PHARMS USA
Approval date: April 20, 2005
Strength(s): 500MG [AB1]
Manufacturer: ZYDUS PHARMS USA
Approval date: April 21, 2005
Strength(s): 750MG [AB]
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM